|
2024
|
Invention
|
Methods for evaluating and improving cognitive function.
The present invention generally relates... |
|
|
Invention
|
Autophagy-inducing peptides. The present disclosure relates to peptides capable of inducing autop... |
|
|
Invention
|
Stapled peptides. The present disclosure relates to a peptide comprising two α,α-disubstituted am... |
|
2023
|
Invention
|
Compounds with mertk activity. The present invention provides compounds of Formula (I), which hav... |
|
|
Invention
|
Methods for producing polypeptide variants. Provided herein are methods for the selection or dire... |
|
|
Invention
|
Hydrogel and uses thereof. The present invention relates to biocompatible hydrogels, in particula... |
|
|
Invention
|
Dimers and uses therefor. Disclosed are proteinaceous molecule dimers represented by Formula I, m... |
|
2022
|
Invention
|
Compositions and methods for the treatment of pcdh19 related disorders. Provided herein are antis... |
|
|
Invention
|
Determining properties of samples using quantum sensing. A method for determining one or more pro... |
|
|
Invention
|
Encapsulation of eukaryotic cells for cellular screening of expressed sequences.
Methods for sel... |
|
|
Invention
|
Compositions, kits, and methods for detecting preclinical alzheimer's disease. Compositions and k... |
|
|
Invention
|
Receptor antagonists and uses therefor. Provided herein are peptides comprising an A chain and a ... |
|
|
Invention
|
Methods for inducing vasodilation.
Provided herein are methods for preventing or minimising hypo... |
|
|
Invention
|
Methods for mediating vasoconstriction. Provided herein are methods for inducing vasoconstriction... |
|
|
Invention
|
Methods for inducing vasodilation. Provided herein are methods for preventing or minimising hypop... |
|
2021
|
Invention
|
Peptide-based delivery of agents.
Described herein are fusion peptides comprising (i) a peptide ... |
|
|
Invention
|
Peptide-based delivery of agents. Described herein are fusion peptides comprising (i) a peptide s... |
|
|
Invention
|
Compositions and methods for treating disorders associated with loss-of-function mutations in scn... |
|
|
Invention
|
System and device for quantifying motor control disorder.
A movement monitoring system for objec... |
|
|
Invention
|
System and device for quantifying motor control disorder. A movement monitoring system for object... |
|
|
Invention
|
Compositions and methods for treating disorders associated with loss-of-function mutations in syn... |
|
|
Invention
|
Treatment for sepsis-induced organ dysfunction.
Provided herein are methods for treating or prev... |
|
|
Invention
|
Treatment for sepsis-induced organ dysfunction. Provided herein are methods for treating or preve... |
|
2020
|
Invention
|
Derivatisation of peptides and proteins.
The present disclosure relates to methods for preparing... |
|
2019
|
Invention
|
Compositions and implantable devices.
The present disclosure relates generally to a composition ... |
|
|
Invention
|
Compositions and implantable devices. The present disclosure relates generally to a composition f... |
|
|
Invention
|
Methods of treating neurodevelopmental diseases and disorders. The present invention relates gene... |
|
2018
|
Invention
|
Methods for evaluating and improving cognitive function. The present invention generally relates ... |
|
|
Invention
|
Compositions and methods for treating conditions associated with gain-of-function mutations in kc... |
|
|
Invention
|
Encapsulation of eukaryotic cells for cellular screening of expressed sequences.
Provided herein... |
|
|
Invention
|
Encapsulation of eukaryotic cells for cellular screening of expressed sequences. Provided herein ... |
|
|
Invention
|
Prophylaxis and treatment of cognitive dysfunction and decline. Provided in accordance with the p... |
|
2016
|
Invention
|
Proteinaceous molecules and methods of use. v1.1 activity. |
|
|
Invention
|
Proteinaceous molecules and methods of use. This invention relates to peptides and their use for ... |
|
|
Invention
|
Methods of treating or alleviating mental disorders and associated symptoms. The present inventio... |
|
|
Invention
|
4h-pyran compounds as insulin-regulated aminopeptidase (irap) inhibitors. The present disclosure ... |
|
|
Invention
|
Sodium channel modulators. The present disclosure relates generally to compounds having activity ... |
|
2015
|
Invention
|
Methods of treating neurodevelopmental diseases and disorders. H:\svm\Interwoven\NRPortbl\DCC\SVM... |
|
|
Invention
|
Modified relaxin b chain peptides. Provided herein are biologically active single chain relaxin p... |
|
2012
|
Invention
|
Methods for determining binding capability of target ligands with g protein-coupled receptors usi... |
|
|
Invention
|
Modifying single proteins (gpcr), ligands, and nanopore surfaces to create binding-induced molecu... |
